You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Siltuximab

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) Trial in Nantes (Siltuximab)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • Siltuximab
  • Nantes, France
    CHU de Nantes
Jan 24, 2023

Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

Active, not recruiting
  • Multiple Myeloma
  • AL Amyloidosis
  • Siltuximab
  • The M.D. Anderson Symptom Inventory (MDASI)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Non-Hodgkin Lymphoma Trial in Columbus (Biospecimen Collection, Computed Tomography, Positron Emission Tomography)

Recruiting
  • Non-Hodgkin Lymphoma
  • Biospecimen Collection
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Jan 13, 2023

Schwannomatosis, Schwannomas, Pain, Chronic Trial in Boston (Siltuximab, Erenumab-Aooe, Siltuximab Matching Placebo)

Not yet recruiting
  • Schwannomatosis
  • +2 more
  • Siltuximab
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 5, 2023

Large Granular Lymphocyte Leukemia Trial in Tampa (Siltuximab)

Recruiting
  • Large Granular Lymphocyte Leukemia
  • Siltuximab
  • Tampa, Florida
    Moffitt Cancer Center
Mar 30, 2022

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Cytokine Release Syndrome, ICANS, Lymphoma, Non-Hodgkin Trial in Birmingham (Siltuximab)

Recruiting
  • Cytokine Release Syndrome
  • +4 more
  • Siltuximab
  • Birmingham, Alabama
    University of Alabama at Birmingham
Nov 17, 2021

Schizophrenia, Psychotic Disorders Trial in Augusta (Siltuximab, normal saline)

Recruiting
  • Schizophrenia
  • Psychotic Disorders
  • Siltuximab
  • normal saline
  • Augusta, Georgia
    Augusta University
Jul 27, 2021

Idiopathic Multicentric Castleman's Disease Trial in Lansing (Siltuximab)

Terminated
  • Idiopathic Multicentric Castleman's Disease
  • Siltuximab
  • Lansing, Michigan
    Edward W. Sparrow Hospital
Apr 15, 2021

Acute Respiratory Distress Syndrome, Lung Diseases, Pneumonia Trial in Lansing, Charlotte (Siltuximab, Normal Saline)

Terminated
  • Acute Respiratory Distress Syndrome
  • +4 more
  • Siltuximab
  • Normal Saline
  • Lansing, Michigan
  • +1 more
Apr 15, 2021

Siltuximab in Patients Diagnosed With COVID-19 Infection Who

Completed
  • Severe Acute Respiratory Syndrome (ARDS) Secondary to SARS-COV-2 Infection
    • Bergamo, Italy
      ASST - Papa Giovanni XXIII
    May 28, 2020

    Anti-IL6 and Corticosteroid Monotherapy vs Combination in

    Recruiting
    • Critical Illness
    • +2 more
    • Interleukin 6 (IL6) Antagonist
    • +2 more
    • Riyadh, Saudi Arabia
      King Faisal Specialist Hospital and Research Center
    Mar 4, 2021

    COVID-19 Trial in Spain (Siltuximab, Methylprednisolone)

    Unknown status
    • COVID-19
    • Badalona, Spain
    • +3 more
    Apr 16, 2020

    COVID-19 Trial in Belgium (Usual Care, Anakinra, Siltuximab)

    Completed
    • COVID-19
    • Usual Care
    • +3 more
    • Brugge, Belgium
    • +14 more
    Sep 28, 2021

    High-risk Smoldering Multiple Myeloma Trial in Worldwide (Siltuximab, Placebo)

    Completed
    Has Results
    • High-risk Smoldering Multiple Myeloma
    • Siltuximab
    • Placebo
    • Chicago, Illinois
    • +39 more
    Jan 23, 2020

    Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)

    Recruiting
    • Castleman Disease
    • Castleman's Disease, Multicentric
    • Little Rock, Arkansas
    • +3 more
    Jan 6, 2023

    IL-6 and Its Receptor Antagonists in Children's Severe Sepsis.

    Withdrawn
    • Critical Illness Sepsis, Severe
      • (no location specified)
      Jun 13, 2022

      Type 1 Diabetes Trial in Seattle (Siltuximab)

      Completed
      Has Results
      • Type 1 Diabetes
      • Siltuximab
      • Seattle, Washington
        Benaroya Research Institute
      Oct 5, 2018

      Multiple Myeloma Trial in Worldwide (Siltuximab, Bortezomib, Placebo)

      Completed
      Has Results
      • Multiple Myeloma
      • Siltuximab
      • +3 more
      • Greenbrae, California
      • +83 more
      Nov 7, 2019

      Cancer Target Therapy Efficacy

      Active, not recruiting
      • Cancer
      • RNA sequencing
      • +5 more
      • Walnut, California
      • +6 more
      Sep 13, 2021

      Multicentric Castleman's Disease Trial in Worldwide (Siltuximab)

      Completed
      Has Results
      • Multicentric Castleman's Disease
      • Siltuximab
      • Little Rock, Arkansas
      • +25 more
      Apr 25, 2018

      Tuberculosis, Tubercular Meningitis, Arachnoiditis; Tuberculous (Etiology) Trial (Cyclophosphamide injection)

      Not yet recruiting
      • Tuberculosis
      • +2 more
      • Cyclophosphamide injection
      • (no location specified)
      Dec 29, 2020

      Schizophrenia, Psychotic Disorders Trial in Augusta (Tocilizumab, Normal saline)

      Recruiting
      • Schizophrenia
      • Psychotic Disorders
      • Augusta, Georgia
        Augusta University
      Jul 27, 2021

      Multicentric Castleman's Disease Trial in Worldwide (Siltuximab, Placebo, Best Supportive Care (BSC))

      Completed
      Has Results
      • Multicentric Castleman's Disease
      • Siltuximab
      • +2 more
      • Little Rock, Arkansas
      • +56 more
      Feb 22, 2018

      Advanced Lung Cancer Trial in Guangzhou (CAR-T cells to treat advanced lung cancer)

      Terminated
      Has Results
      • Advanced Lung Cancer
      • CAR-T cells to treat advanced lung cancer
      • Guangzhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Jul 9, 2020